Carregant...
Mechanisms of Androgen Receptor Activation in Castration-Resistant Prostate Cancer
Systemic treatment of advanced prostate cancer is initiated with androgen deprivation therapy by gonadal testosterone depletion. Response durations are variable and tumors nearly always become resistant as castration-resistant prostate cancer (CRPC), which is driven, at least in part, by a continued...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Endocrine Society
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3948917/ https://ncbi.nlm.nih.gov/pubmed/24002034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2013-1466 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|